17th Annual Medical Device Coverage & Reimbursement Conference

Healthcare and FDA practice's Andrew Tsui will be speak at Part 1 of the conference's MCIT discussion titled "Deciphering CMS’ Medicare Coverage of Innovative Technologies Rule & Upcoming Impact on Device Reimbursement" on September 15-16, 2021. As outlined online, the program will discuss topics including expediting access to reimbursed innovative medical devices, the impact of MCIT rule on cutting-edge technology availability and alternative pathways for novel device coverage with or without MCIT adoption.